Non-criteria manifestations of juvenile antiphospholipid syndrome T Miyamae, T Kawabe Journal of Clinical Medicine 10 (6), 1240, 2021 | 13 | 2021 |
Association of disease activity using SDAI and DAS28, but not JADAS-27, with subsequent changes in physical function in adult patients with juvenile idiopathic arthritis T Miyamae, E Inoue, E Tanaka, T Kawabe, K Ikari, M Harigai Modern Rheumatology 33 (3), 588-593, 2023 | 2 | 2023 |
Epidemiology conduction of paediatric rheumatic diseases based on the registry database of the Pediatric Rheumatology Association of Japan H Narazaki, S Akioka, Y Akutsu, M Araki, M Fujieda, D Fukuhara, R Hara, ... Modern Rheumatology 33 (5), 1021-1029, 2023 | 1 | 2023 |
POS0760 LONG-TERM PROGNOSTIC FOLLOW-UP OF PATIENTS WITH REFRACTORY SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS AFTER THE CLINICAL TRIAL OF TOCILIZUMAB AS A FIRST-LINE BIOLOGIC TREATMENT T Miyamae, T Kawabe, K Nishimura, S Hattori, T Imagawa, T Ishii, S Ito, ... Annals of the Rheumatic Diseases 82 (Suppl 1), 671-672, 2023 | | 2023 |
POS1298 RELATIONSHIP BETWEEN DISEASE ACTIVITY BY JADAS-27, SDAI, AND DAS-28 AND SUBSEQUENT CHANGES IN PHYSICAL FUNCTION IN ADULT PATIENTS WITH JUVENILE IDIOPATHIC ARTHRITIS T Miyamae, E Inoue, E Tanaka, T Kawabe, K Ikari, M Harigai Annals of the Rheumatic Diseases 81 (Suppl 1), 986-987, 2022 | | 2022 |